Article Information
vol. 31 no. 166
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 20, 2022
- Accepted October 9, 2022
- Published online November 29, 2022.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
Author Information
- Mona Bafadhel1⇑,
- Rosa Faner2,
- Camille Taillé3,
- Richard E.K. Russell1,
- Tobias Welte4,
- Peter J. Barnes5 and
- Alvar Agustí6
- 1King’s Centre for Lung Health, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, UK
- 2CIBER Enfermedades Respiratorias, IDIBAPS, Barcelona, Spain
- 3Department of Pulmonary Diseases, University Hospital Bichat-Claude Bernard, AP-HP Nord, University of Paris, Paris, France
- 4Department of Pulmonary and Infectious Diseases, Hannover University School of Medicine, Hannover, Germany
- 5National Heart and Lung Institute, Imperial College London, London, UK
- 6Cátedra de Salud Respiratoria (University of Barcelona), Respiratory Institute (Hospital Clinic Barcelona), IDIBAPS and CIBERES, Barcelona, Spain
- Corresponding author: Mona Bafadhel (mona.bafadhel{at}kcl.ac.uk)
Funding
AstraZeneca
